These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9579490

  • 1. Sensitive physiologic imaging with contrast-enhanced magnetic resonance imaging.
    Litt L.
    Anesthesiology; 1998 Apr; 88(4):847-50. PubMed ID: 9579490
    [No Abstract] [Full Text] [Related]

  • 2. Important considerations in the design of iron oxide nanoparticles as contrast agents for TI-weighted MRI and MRA.
    Kellar KE, Fujii DK, Gunther WH, Briley-Saebø K, Bjornerod A, Spiller M, Koenig SH.
    Acad Radiol; 2002 May; 9 Suppl 1():S34-7. PubMed ID: 12019889
    [No Abstract] [Full Text] [Related]

  • 3. Pitfalls in employing superparamagnetic iron oxide particles for stem cell labelling and in vivo MRI tracking.
    Wang YX, Wang HH, Au DW, Zou BS, Teng LS.
    Br J Radiol; 2008 Dec; 81(972):987-8. PubMed ID: 19029055
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Re: Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.
    Kroon BK, Horenblas S.
    J Urol; 2006 Mar; 175(3 Pt 1):1174. PubMed ID: 16469648
    [No Abstract] [Full Text] [Related]

  • 6. Real enhancement or merely increased contrast?
    Chen JH.
    AJR Am J Roentgenol; 1997 Jan; 168(1):279-80. PubMed ID: 8976963
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future.
    Soyer P.
    Radiology; 1996 Sep; 200(3):610-1. PubMed ID: 8756902
    [No Abstract] [Full Text] [Related]

  • 10. Splenic magnetic resonance imaging using particulate agents.
    Small WC, Nelson RC, Sherbourne GM, Bernardino ME.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S12-4. PubMed ID: 7928204
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Improved tumor diagnosis using MRI with organ-specific contrast media. Wiesbaden, 12 May 1999].
    Rofo; 1999 Jul; 171(1 Suppl):1-4. PubMed ID: 10467439
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.